Concepedia

Aisong Yu

AY

Statistics

Publications

5

Citations

123

H-Index

5

Active since

2018

Affiliations

Shanghai Institute of Materia Medica(Current)

Chinese Academy of Sciences

University of Chinese Academy of Sciences

Aisong Yu is an author at Shanghai Institute of Materia Medica specializing in lysine methyltransferase activity, medicinal chemistry, and histone methyltransferase inhibition.

Publications per year

2018–2024

5

Publications

5

Discovery of a potent and selective proteolysis targeting chimera (PROTAC) degrader of NSD3 histone methyltransferase

Yaoliang Sun, Ying Zhang, Xiaoai Chen et al. · European Journal of Medicinal Chemistry · 2022 · 38 citations · Full text

, , +14

Piribedil disrupts the MLL1-WDR5 interaction and sensitizes MLL-rearranged acute myeloid leukemia (AML) to doxorubicin-induced apoptosis

Xiong Zhang, Xingling Zheng, Hong Yang et al. · Cancer Letters · 2018 · 29 citations

, , +14

Structure-Based Discovery of a Series of NSD2-PWWP1 Inhibitors

Na Li, Hong Yang, Ke Liu et al. · Journal of Medicinal Chemistry · 2022 · 24 citations · Full text

, , +15

Structural Modification and Pharmacological Evaluation of Substituted Quinoline-5,8-diones as Potent NSD2 Inhibitors

Hairong Tang, Aisong Yu, Xing Li et al. · Journal of Medicinal Chemistry · 2023 · 22 citations · Full text

, , +13

<scp>GV</scp>‐971 attenuates the progression of neuromyelitis optica in murine models and reverses alterations in gut microbiota and associated peripheral abnormalities

Xinying Yang, Zhongheng Zhangyi, Aisong Yu et al. · CNS Neuroscience & Therapeutics · 2024 · 10 citations · Full text

, , +17

1–5 of 5